Synthego IPO

synthego.com

Synthego was founded in 2012 by Alex Pesch, Michael Dabrowski, and Paul Dabrowski. When asked about a potential IPO, CEO Dabrowski said that while "We think we can basically be ready for that anytime... From a publicity standpoint, from a people and teams standpoint, a financial capital needs standpoint, now we’ve decided to stay private." These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.

Synthego is a genome engineering company leveraging machine learning, automation, and gene editing to build platforms at scale. The company is a major developer of the tools which are used in CRISPR therapies, citing more than 1,000 peer-reviewed studies that have used its technology in at least one step. The company has raised more than $450 million in venture capital funding from investors including Perceptive Advisors LLC, SoftBank Vision Fund 2, Moore Strategic Ventures, Declaration Partners, Laurion Capital Management, and Logos Capital. Synthego did not release valuation information after a $200 million equity round in early 2022, but it is estimated at between $800 million and $1.2 billion.

Founded2012
Total Funding to Date$415.07MM
Register for Details

For more details on financing and valuation for Synthego, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Synthego Ticker Symbol

Synthego does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Synthego Stock Price

The stock price for Synthego will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Synthego Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
2/17/2022 Series E $1.3B $XXX.XX $XXX.XX
8/26/2020 Series D $486.63MM $XXX.XX $XXX.XX
10/23/2018 Series C $381.27MM $XXX.XX $XXX.XX
1/4/2017 Series B and B-1 $111MM $XXX.XX $XXX.XX
7/5/2013 Series A $23.7MM $XXX.XX $XXX.XX
Based on primary financings

Other companies like Synthego in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B